Categories
IPPI News

Announcing IPPI + IPPI Spring 2025 Progress Report

Navigation Announcing IPPI: The IP Policy Institute A Message from Faculty Chair Mark Schultz & Executive Director Joshua Kresh IPPI Spring Progress Report (December 2024-February 2025) IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Announcing IPPI: The IP Policy Institute A Message from Faculty Chair Mark Schultz and Executive Director […]

[Archived Post] C-IP2 Winter 2024 Progress Report (September-November 2024)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh Reflecting on this vibrant winter season at the Center for Intellectual Property x Innovation Policy, I am filled with gratitude and excitement. As you can read in the report linked below, which covers this past September through November, we have been active and productive, hosting public […]

Categories
Conferences High Tech Industry Innovation Patent Law Patents Software Patent

[Archived Post] Panel on “SEP Current & Proposed Regulations” at C-IP2’s 2024 Annual Fall Conference

By Keith Mallinson It was my pleasure to participate in a panel session on “SEP Current & Proposed Regulations” last month at the George Mason University Antonin Scalia Law School Center for Intellectual Property x Innovation Policy (C-IP2) Annual Fall Conference entitled “The Importance of Exclusive Rights.” The other panelists were Angela Barr, Mark Cohen, […]

Categories
Conferences Innovation Inventors Patent Law Patents

[Archived Post] Panelists at George Mason’s IP conference debate litigation funding

By Kristen Osenga I recently had the pleasure of participating in a panel on third-party litigation funding (TPLF), which was part of the Annual Fall Conference at George Mason University’s Center for Intellectual Property x Innovation Policy. The panel included experts from both industry and academia, highlighted the growing debate around TPLF, and crystallized why […]

Categories
Biotech Healthcare Innovation Patent Law Patents Pharma

[Archived Post] What the FTC Gets Wrong About the FDA’s Orange Book

By Emily Michiko Morris & Douglas Park The high cost of some pharmaceuticals is a complex issue, but the Federal Trade Commission’s (FTC’s) most recent criticism of pharmaceutical patents’ role is misguided. The FTC has criticized the listing of drug product device patents in the FDA’s “Orange Book,” a listing of patents related to various […]

Categories
Copyright Copyright Licensing Fair Use Infringement

[Archived Post] Copyright and Tattoos: New Amicus Brief in Sedlik v. Von Drachenberg; Oct. 29 Virtual Clinic for Visual Artists

CIP2 congratulates the Arts & Entertainment Advocacy Clinic at Scalia Law, led by Professor Sandra Aistars, and Student Advocate Natalie Nachman, and supported by Counsel of Record Matt Hersh of Mestaz Law, for filing a powerful amicus brief on behalf of three Tattoo Artists in the 9th Circuit Court of Appeals this week in Sedlik […]

Categories
C-IP2 News CPIP Roundup

[Archived Post] C-IP2 Fall 2024 Progress Report (June-August 2024)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh As we transition into the fall season, I am delighted to share that we have had a productive summer and are looking forward to an eventful fall and winter. The past months have been marked by significant achievements and exciting developments, building upon the robust foundation […]

Categories
Uncategorized

[Archived Post] NO FAKES Act: Unpacking the New Bipartisan Bill on Digital Replicas

The following post was originally published on the Patently-O blog and is cross-posted here with permission from both Patently-O and the author. Senators aim to rein in digital replicas with the “NO FAKES” Act which proposes a limited federal right to control one’s likeness using some DMCA-like notice-and-takedown elements. Guest post by Professor Justin Hughes […]

Categories
Artificial Intelligence Copyright Uncategorized

[Archived Post] Authors are Humans and Creativity is a Function of Humanness: What the Mannion Court Can Teach Us About Generative AI’s Relationship to Authorship

By Molly Stech* * The blog post below and the law review article it links to are the individual thoughts and views of the author and should not be attributed to any entity with which she is currently or has been affiliated. Despite a recent decision from the Beijing Internet Court, there is growing consensus […]

Categories
C-IP2 News

[Archived Post] C-IP2 Summer 2024 Progress Report (March-May 2024)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am pleased to report that we have had a productive spring and are working on several items for this summer and fall. Since our last report, we published several policy briefs on pending legislation, held our launch event for our 5G book, welcomed our new […]